Casivirimab/Imdevimab for severe COVID-19 Pneumonia during Rituximab Induction Therapy for ANCA-associated Vasculitis

Herold, J.; Zwickel, P.; Geis, F.; van Drongelen, N.; Rosenberg, M.; Buttner, S.

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Casivirimab/Imdevimab for severe COVID-19 Pneumonia during Rituximab Induction Therapy for ANCA-associated Vasculitis

Herold, J.; Zwickel, P.; Geis, F.; van Drongelen, N.; Rosenberg, M.; Buttner, S..

Medizinische Klinik-Intensivmedizin Und Notfallmedizin ; 116(SUPPL 2):54-55, 2021.

Article in German | Web of Science | ID: covidwho-1260320

Search on Google

Print

XML

Collection: Databases of international organizations Database: Web of Science Language: German Journal: Medizinische Klinik-Intensivmedizin Und Notfallmedizin Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

Print

XML

Collection: Databases of international organizations Database: Web of Science Language: German Journal: Medizinische Klinik-Intensivmedizin Und Notfallmedizin Year: 2021 Document Type: Article